Acquiring Company
Cartesian Therapeutics, Inc.
Acquired Company
Cartesian Therapeutics, Inc.
GaithersburgGaithersburgBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Selecta Biosciences has successfully merged with Cartesian Therapeutics as part of its strategic transformation. This merger enhances Selecta's immune tolerance platform and expands its capabilities in RNA cell therapy. The combined expertise will target autoimmune diseases and improve treatment efficacy in gene therapies. This partnership marks a significant step for Selecta in the biotech industry as it evolves its operational model.
Quick answer
Cartesian Therapeutics, Inc. is acquiring Cartesian Therapeutics, Inc., announced May 17, 2026. Cartesian Therapeutics, Inc. is based in Gaithersburg, Maryland, United States.
- Who acquired Cartesian Therapeutics, Inc?
- Cartesian Therapeutics, Inc. agreed to acquire Cartesian Therapeutics, Inc. on May 17, 2026.
- How much did Cartesian Therapeutics, Inc. pay for Cartesian Therapeutics, Inc?
- The deal value was not disclosed.
- Where are Cartesian Therapeutics, Inc. and Cartesian Therapeutics, Inc. based?
- Cartesian Therapeutics, Inc. is based in Gaithersburg, Maryland, United States. Cartesian Therapeutics, Inc. is based in Gaithersburg, Maryland, United States.
- Who are the decision-makers at Cartesian Therapeutics, Inc?
- Fundz holds 1 contact at Cartesian Therapeutics, Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Biopharma
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Gilead Sciences to acquire MacroGenics for $1.7B, $1.7B (May 19, 2026)
- XTL acquires majority stake in Psyga Bio Ltd. (June 30, 2026)
- Redx Pharma completes reverse merger with Jounce Therapeutics (June 19, 2026)
- Otsuka acquires Transcend Therapeutics for $700M, $700M (June 12, 2026)
- Incyte acquires Vega Therapeutics for $1.25 billion, $1.3B (June 8, 2026)
- Galmed Pharmaceuticals to acquire Colospan for GI focus (June 8, 2026)
Who to call at Cartesian Therapeutics, Inc., and when
When Cartesian Therapeutics, Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Cartesian Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cartesian Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cartesian Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cartesian Therapeutics, Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Cartesian Therapeutics, Inc.?
Cartesian Therapeutics, Inc. was acquired by Cartesian Therapeutics, Inc., based in Gaithersburg. The deal was reported on May 17, 2026. Cartesian Therapeutics, Inc. is publicly traded (RNAC) and operates in Biotechnology.
When did Cartesian Therapeutics, Inc. acquire Cartesian Therapeutics, Inc.?
Cartesian Therapeutics, Inc.'s acquisition of Cartesian Therapeutics, Inc. was reported on May 17, 2026. Selecta Biosciences has successfully merged with Cartesian Therapeutics as part of its strategic transformation. This merger enhances Selecta's immune tolerance platform and expands its capabilities in RNA cell therapy. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cartesian Therapeutics, Inc. do?
Cartesian Therapeutics, Inc. is the company acquired in this transaction. It is publicly traded (RNAC), operating in Biotechnology, and is based in Gaithersburg.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.